
Jennifer Litton
@jenniferlitton
Breast Medical Oncologist at MDAnderson. Vice President Clinical Research. Tweets and opinions are my own.
ID: 1392753566
30-04-2013 18:34:13
660 Tweet
1,1K Followers
961 Following



Drugs that got accelerated approval may be the only option for patients with rare or advanced cancers, says our Dr. Jennifer Litton. “It’s important for doctors to carefully explain the evidence.” Learn more: brnw.ch/21wID60 The Associated Press Jennifer Litton #EndCancer


Congratulations, Dr. Hunt. We are proud to have you on our team and are grateful for your commitment to #EndCancer. Kelly K Hunt


At #ASCO24? Be sure to stop by the MD Anderson Cancer Center booth (#13069) for our Meet the Experts sessions and to grab a coffee. Find out more info at MDAnderson.org/ASCO. #EndCancer



Our Dr. Jason Westin shares insights on how CAR-T therapy could improve first-line therapy in some lymphoma patients: bit.ly/3VXzPNv Jason Westin, MD FACP FASCO #EndCancer

Thank you to the SITC breast cancer CPG expert panel for their contributions. @DrGattiMays Jennifer Litton Mary L. (Nora) Disis Kevin Kalinsky, MD, MS, FASCO Heather McArthur, MD, MPH, FASCO Rita Nanda Hope Rugo Sara Tolaney

Starting tomorrow, MD Anderson experts will present the latest advances in cancer care at the European Society for Medical Oncology Congress. Read highlights from presentations and details about onsite opportunities: MDAnderson.org/ESMO ESMO - Eur. Oncology #ESMO24 #EndCancer


Looking forward to this ALL STAR Jim Allison Institute symposium on #Immunotherapy in Space and Time at MD Anderson Cancer Center tomorrow. mdanderson.org/research/resea…



We’re days out from the ice storm that will impact blood supply MD Anderson Cancer Center. Take 30 minutes this weekend (or during a half day on Monday) to make a difference by donating blood for our cancer patients. Make an appointment at MDAndersonBloodBank.org. #EndCancer


Great case discussions from our GU team reviewing adjuvant pembro this morning. And remembering Chris Wood. MD Anderson Cancer Center



To all SITC members - election starts May 2 and I would strongly encourage consideration of Dr. Tina Cascone as a dynamic and visionary physician scientist and translational researcher. A true pioneer and leader in the lung cancer space. Society for Immunotherapy of Cancer sitcancer.org/membership/202…


Thanks to a generous $150 million gift from Kinder Foundation, we announce the launch of Kinder Children’s Cancer Center. This joint venture of UT MD Anderson and Texas Children's has a single mission: to #EndChildhoodCancer. brnw.ch/21wSEOo #UTMDAnderson_TexasChildrens

Huge congratulations to our incredible mentor, Dr. Mariana Chavez MacGregor, on being named MD Anderson Cancer Center Mentor of the Year! I’m greatly appreciative of your guidance, unwavering support and sponsorship. So well deserved! ✨


Scott Kopetz MD Anderson Cancer Center . starting the scientific portion of research townhall on cancer evolution. Tune in!
